Article Sidebar

PDF
Date Published: 05/01/2022
Abstract Views: 109
Views PDF: 175
DOI: https://doi.org/10.51298/vmj.v508i1.1547
Issue
Vol. 508 No. 1 (2021)
Section
Các bài báo
How to Cite
Đăng Quang, T. ., & Tuấn Anh, V. . (2022). RESULTS OF VITRECTOMY USING PFCL FOR TREATMENT OF DIABETIC TRACTIONALRETINAL DETACHMENT. Vietnam Medical Journal, 508(1). https://doi.org/10.51298/vmj.v508i1.1547

RESULTS OF VITRECTOMY USING PFCL FOR TREATMENT OF DIABETIC TRACTIONALRETINAL DETACHMENT

Trần Đăng Quang1, Vũ Tuấn Anh2,
1 Hanoi Medical University
2 Central Eye Hospital

Main Article Content

Abstract

Aims: results of surgery using PFCL for treatment ofdiabetictractional retinal detachment. Methods: interventional cases series. Patients received an Avastinintravitreal injection prior to undergoing vitrectomy to remove hemorrhage, traction and re-attach the retina. Results: for 21 cases, results 3 months after surgery: 95,2% of  cases retinal re-attached (20/21), visual recovery. Complications as high IOP, vitreous hemorrhage, secondảy epiretinal membrane. Conclusion: vitrectomy using PFCL  for treatment ofdiabetic tractional retinal detachment have good outcomes for anatomical and visual recovery,prevent blindness and savevision for patients with complicated diabetic.

Article Details

Keywords

diabetic tractional retinal detachment, vitrectomy, PFCL

References

1. Haidt SJ, Clark LC, Ginsberg J. Liquid perfluorocarbon replacement in the eye.Invest Ophthalmol Vis Sci,.Published online 1982:22.
2. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy.Am J Ophthalmol. 1988;106(6):668-674. doi: 10.1016/ 0002-9394 (88)90698-8
3. Arevalo JF, Serrano MA, Arias JD. Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment. World J Diabetes. 2014;5(5): 724-729. doi:10.4239/wjd.v5.i5.724
4. Imamura Y. Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. British Journal of Ophthalmology. 2003;87(5):563-566. doi:10.1136/bjo.87.5.563
5. Sato T, Tsuboi K, Nakashima H, Emi K. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(4):665-671. doi:10.1007/s00417-016-3522-8
6. Yang C-M, Yeh P-T, Yang C-H. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology. 2007;114(4):710-715. doi: 10.1016/ j.ophtha.2006.07.047
7. Meleth AD, Carvounis PE. Outcomes of vitrectomy for tractional retinal detachment in diabetic retinopathy.Int Ophthalmol Clin. 2014;54(2):127-139. doi:10.1097/IIO.0000000000000021
8. Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(3):365-368. doi:10.1136/bjo.2007.124495
9. Christensen UC, la Cour M. Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers. Acta Ophthalmol. 2012; 90(8): 733-737. doi:10.1111/ j.1755-3768. 2011.02248.x